UK court reaffirms its stringent plausibility standard in AstraZeneca despite G 2/21 By Annsley Merelle Ward on Friday, May 09, 2025 #IPKat AstraZeneca epc G 2/21 Michael Tappin QC patent litigation plausibility SPC sufficiency Teva UK +
Around the IP Blogs! By Tosshan Ramgolam on Wednesday, January 23, 2019 AstraZeneca Beijing Treaty Berne Convention Erik Brunetti IP Marc Jacobs National Hockey League NHL Nirvana Sale of Goods Act 1970 sandoz Stanley Cup USPTO +
Never Too Late: If you missed the IPKat Last Week! By Tian Lu on Wednesday, July 05, 2017 AIPPI amazon Apotex AstraZeneca Covfefe google injunctions IP lawyer IP Minister patent drawings patent infringement pirate bay. SPCs Tian Lu trade secret upc Venmo +
When the biter gets bit: Cross-undertakings in damages By David Brophy on Friday, May 22, 2015 [2015] EWCA Civ 484 AstraZeneca cross undertaking in damages esomeprazole KRKA nexium +
The skilled person - more knowledgeable than ever before By David Brophy on Thursday, September 04, 2014 asthma AstraZeneca cgk common general knowledge Second medical use Teva +
Feeling fine? Europe enriched by AstraZeneca's millions By Jeremy on Thursday, December 06, 2012 abuse of dominant position AstraZeneca european commission Jeremy Phillips +
AstraZeneca fine looks fine, says AG Mazák By Jeremy on Tuesday, May 15, 2012 AstraZeneca competition law european commission Jeremy Phillips patents +